ISEQ down, Elan still slipping

The ISEQ was down 26.45 points mid-morning at 6345.17, as Elan continued to slide.

After yesterday’s disastrous news of the death of a patient who was being treated with Elan’s multiple sclerosis drug Tysabri, shares in the pharmaceutical fell 96c (14.8%) this morning to €5.53.